Cigna vs Costco Stock: Which Is Best?
Cigna and Costco don’t usually go hand in hand but…
Buy
54
MKL Quote, Financials, Valuation and Earnings
Last price:
$1,775.40
Seasonality move
:
8.48%
Day range:
$1,744.16 - $1,776.68
52-week range:
$1,342.66 - $1,809.11
Dividend yield:
0%
P/E ratio:
8.16x
P/S ratio:
1.34x
P/B ratio:
1.39x
Volume:
71K
Avg. volume:
54.6K
1-year change:
23.6%
Market cap:
$22.8B
Revenue:
$15.7B
EPS (TTM):
$216.78
Analysts' Opinion
-
Consensus RatingMarkel Group has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 7 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $1,697.67, Markel Group has an estimated downside of -4.04% from its current price of $1,769.04.
-
Price Target UpsideAccording to analysts, the highest upside price target is $1,836.00 representing 3.79% upside increase from its current price of $1,769.04.
Fair Value
-
According to the consensus of 8 analysts, Markel Group has -4.04% downside to fair value with a price target of $1,697.67 per share.
MKL vs. S&P 500
-
Over the past 5 trading days, Markel Group has overperformed the S&P 500 by 1.67% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Markel Group does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Markel Group has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Markel Group reported revenues of $4.5B.
Earnings Growth
-
Markel Group has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Markel Group reported earnings per share of $66.25.
Enterprise value:
17.8B
EV / Invested capital:
--
Price / LTM sales:
1.34x
EV / EBIT:
4.34x
EV / Revenue:
1.03x
PEG ratio (5yr expected):
0.15x
EV / Free cash flow:
6.77x
Price / Operating cash flow:
8.81x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
5.17%
Net Income Margin (TTM):
17.16%
Return On Equity:
18.44%
Return On Invested Capital:
14.75%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $11.5B | $15.3B | $17.3B | $3.4B | $4.5B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -$10.13 | $139.54 | $216.78 | $3.14 | $66.25 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $25.9B | $29.8B | $31.2B | $25.2B | $28.6B | |
| Total Assets | $40.2B | $46.7B | $48.4B | $52.7B | $62.3B | |
| Current Liabilities | $5.9B | $7.2B | $8.5B | $924.6M | $11.7B | |
| Total Liabilities | $28B | $32.4B | $35.5B | $38.2B | $44.6B | |
| Total Equity | $12.1B | $14.3B | $12.9B | $14.5B | $17.7B | |
| Total Debt | $3.5B | $4.3B | $4.1B | $3.8B | $4.4B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.5B | $2.8B | $2.9B | $955.7M | $890.8M | |
| Cash From Investing | -$1.5B | -$1.7B | -$3.2B | -$969.1M | -$326.1M | |
| Cash From Financing | -$560.7M | -$903.5M | -$134.7M | -$169.4M | -$189.5M | |
| Free Cash Flow | $2.3B | $2.6B | $2.6B | $880M | $838.9M | |
MKL
Sector
Market Cap
$22.8B
$677.2M
Price % of 52-Week High
97.79%
88.11%
Dividend Yield
0%
2%
Shareholder Yield
2.26%
3.88%
1-Year Price Total Return
23.6%
8.99%
Beta (5-Year)
0.777
0.738
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
1.21%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$1,710.34
200-day SMA
Buy
Level
$1,598.58
Bollinger Bands (100)
Buy
Level
1557.7 - 1722.48
Chaikin Money Flow
Buy
Level
9M
20-day SMA
Buy
Level
$1,718.21
Relative Strength Index (RSI14)
Buy
Level
61.67
ADX Line
Buy
Level
24.54
Williams %R
Sell
Level
-5.6521
50-day SMA
Buy
Level
$1,713.44
MACD (12, 26)
Buy
Level
2.83
25-day Aroon Oscillator
Sell
Level
-84
On Balance Volume
Neutral
Level
10.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.5647)
Sell
CA Score
(Annual)
Level (-1.1673)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-1.073)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Markel's primary business is property and casualty insurance. The company focuses primarily on specialty lines, ranging from areas such as executive liability to commercial equine insurance. The acquisition of Alterra in 2013 added substantial reinsurance operations, which now account for a little less than 15% of premiums. The company uses capital generated by its insurance operations to buy noninsurance operations in diverse areas, such as bakery equipment manufacturing and residential homebuilding.
Stock Forecast FAQ
In the current month, MKL has received 1 Buy ratings 7 Hold ratings, and 0 Sell ratings. The MKL average analyst price target in the past 3 months is $1,697.67.
-
Where Will Markel Group Stock Be In 1 Year?
According to analysts, the consensus estimate is that Markel Group share price will drop to $1,697.67 per share over the next 12 months.
-
What Do Analysts Say About Markel Group?
Analysts are divided on their view about Markel Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Markel Group is a Sell and believe this share price will rise from its current level to $1,500.00.
-
What Is Markel Group's Price Target?
The price target for Markel Group over the next 1-year time period is forecast to be $1,697.67 according to 8 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is MKL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Markel Group is a Hold. 7 of 8 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of MKL?
You can purchase shares of Markel Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Markel Group shares.
-
What Is The Markel Group Share Price Today?
Markel Group was last trading at $1,775.40 per share. This represents the most recent stock quote for Markel Group. Yesterday, Markel Group closed at $1,769.04 per share.
-
How To Buy Markel Group Stock Online?
In order to purchase Markel Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will T-Mobile Stock Recover?
Last year was a stellar year for telecom giant T-Mobile…
Why Is Stanley Druckenmiller Buying Citigroup?
As recently as 2020, few analysts could have predicted that…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 38x
Sell
47
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 112x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
45
NUTX alert for Jan 17
Nutex Health [NUTX] is up 2.83% over the past day.
Buy
53
QMCO alert for Jan 17
Quantum [QMCO] is down 15.61% over the past day.
Sell
34
NGVT alert for Jan 17
Ingevity [NGVT] is up 1.31% over the past day.
